Practical feasibility of outcomes research in oncology: Lessons learned in assessing drug use and cost-effectiveness in The Netherlands-Reference-Cited by-同舟云学术

Practical feasibility of outcomes research in oncology: Lessons learned in assessing drug use and cost-effectiveness in The Netherlands

Published:2013-01 Issue:1 Volume:49 Page:8-16
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Franken Margreet G.,van Gils Chantal W.M.,Gaultney Jennifer G.,Delwel Gepke O.,Goettsch Wim,Huijgens Peter C.,Steenhoek Adri,Punt Cornelis J.A.,Koopman Miriam,Redekop William K.,Uyl-de Groot Carin A.

Funder

Dutch Health Care Insurance Board (CVZ)

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference34 articles.

1. A common policy framework for evidence generation on promising health technologies;Carbonneil;Int J Technol Assess Health Care,2009

2. Using real-world data for coverage and payment decisions: the ISPOR real-world data task force report;Garrison;Value Health,2007

3. Coverage with evidence development: an examination of conceptual and policy issues;Hutton;Int J Technol Assess Health Care,2007

4. Funding the unfundable: mechanisms for managing uncertainty in decisions on the introduction of new and innovative technologies into healthcare systems;Stafinski;Pharmacoeconomics,2010

5. Access with evidence development in the UK: past experience, current initiatives and future potential;Briggs;Pharmacoeconomics,2010

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Practical Guide for Using Registry Data to Inform Decisions About the Cost Effectiveness of New Cancer Drugs: Lessons Learned from the PHAROS Registry;PharmacoEconomics;2015-02-03

2. Evaluation of Patient Registries Supporting Reimbursement Decisions: The Case of Oxaliplatin for Treatment of Stage III Colon Cancer;Value in Health;2015-01

3. Real-world cost-effectiveness of cetuximab in locally advanced squamous cell carcinoma of the head and neck;European Archives of Oto-Rhino-Laryngology;2014-06-19

4. Cost-effectiveness of rituximab as maintenance treatment for relapsed follicular lymphoma: results of a population-based study;European Journal of Haematology;2014-03-02

5. Dispelling the myths around cancer care delivery: It's not all about costs;Journal of Cancer Policy;2014-03